by Jordana Choucair | Sep 1, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized two COVID-19 vaccines that were redesigned to target Omicron. This is the first time the FDA has granted updated COVID-19 vaccines emergency use authorization. Pfizer’s updated vaccine is authorized for people...
by Jordana Choucair | Sep 1, 2022 | Life Sciences
Florida Governor Ron DeSantis announced he is suing the FDA, claiming that the agency is delaying the state’s attempts at importing cheaper prescription medications from Canada. DeSantis said the FDA has violated federal law by dragging out the approval of the...
by Jordana Choucair | Sep 1, 2022 | M&A
Walgreens Boots Alliance Inc. announced it completed its $330 million investment into CareCentrix, officially securing a 55 percent ownership stake in the at-home care technology platform. Walgreens said the acquisition will help expands its footprint in the primary...
by Jordana Choucair | Sep 1, 2022 | Opioid/Substance Use Disorders
A new study published in JAMA Psychiatry found that the expanded use of telehealth services during the COVID-19 pandemic was associated with a reduced risk of opioid overdoses. Federal researchers compared two cohorts of Medicare beneficiaries before and during the...
by Jordana Choucair | Sep 1, 2022 | Payers
The Centers for Medicare & Medicaid Services (CMS) proposed a rule that would ease the enrollment and renewal processes for Medicaid and Children’s Health Insurance Program benefits. CMS Administrator Chiquita Brooks-LaSure said the change would “ensure that...
Recent Comments